Cormark Has Negative Outlook of Boralex FY2025 Earnings

Boralex Inc. (TSE:BLXFree Report) – Cormark reduced their FY2025 earnings per share estimates for Boralex in a note issued to investors on Thursday, January 23rd. Cormark analyst N. Boychuk now expects that the company will earn $1.01 per share for the year, down from their previous estimate of $1.16. The consensus estimate for Boralex’s current full-year earnings is $1.34 per share.

BLX has been the topic of a number of other reports. CIBC reduced their price objective on shares of Boralex from C$42.00 to C$40.00 and set an “outperform” rating on the stock in a research note on Wednesday, January 8th. BMO Capital Markets reduced their price target on shares of Boralex from C$46.00 to C$45.00 in a research report on Friday, November 15th. Five analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of C$43.13.

Read Our Latest Report on BLX

Boralex Stock Down 2.1 %

TSE BLX opened at C$25.63 on Friday. The company has a current ratio of 0.95, a quick ratio of 1.54 and a debt-to-equity ratio of 175.24. The company has a market cap of C$2.63 billion, a price-to-earnings ratio of 27.56, a PEG ratio of 2.01 and a beta of 0.46. The company has a 50 day moving average of C$28.74 and a 200-day moving average of C$32.16. Boralex has a 1-year low of C$25.55 and a 1-year high of C$36.68.

Boralex Company Profile

(Get Free Report)

Boralex Inc is an electric utility company involved in the development, construction, and operation of renewable energy power facilities. The company controls a portfolio of electricity producing plants that utilize wind, hydroelectric, thermal, and solar fuel sources. Most of Boralex’s plants rely on wind power, while a significant number also employ hydroelectric power.

Further Reading

Receive News & Ratings for Boralex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boralex and related companies with MarketBeat.com's FREE daily email newsletter.